Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Am J Gastroenterol. 2012 Aug;107(8):1205-12. doi: 10.1038/ajg.2012.136. Epub 2012 May 29.
The aim of this randomized study was to determine whether intervention based on additional capnographic monitoring reduces the incidence of arterial oxygen desaturation during propofol sedation for colonoscopy.
Patients (American Society of Anesthesiologists classification (ASA) 1-3) scheduled for colonoscopy under propofol sedation were randomly assigned to either a control arm with standard monitoring (standard arm) or an interventional arm in which additional capnographic monitoring (capnography arm) was available. In both study arms, detection of apnea or altered respiration induced withholding propofol administration, stimulation of the patient, chin lift maneuver, or further measures. The primary study end point was the incidence of arterial oxygen desaturation (defined as a fall in oxygen saturation (SaO(2)) of ≥5% or <90%); secondary end points included the occurrences of hypoxemia (SaO(2) <90%), severe hypoxemia (SaO(2) ≤85%), bradycardia, hypotension, and the quality of sedation (patient cooperation and patient satisfaction).
A total of 760 patients were enrolled at three German endoscopy centers. The intention-to-treat analysis revealed a significant reduction of the incidence of oxygen desaturation in the capnography arm in comparison with the standard arm (38.9% vs. 53.2%; P<0.001). The numbers of patients with a fall in SaO(2) <90% and ≤85% were also significantly different (12.5% vs. 19.8%; P=0.008 and 3.7 vs. 7.8%; P=0.018). There were no differences regarding the rates of bradycardia and hypotension. Quality of sedation was similar in both groups. Results of statistical analyses were maintained for the per-protocol population.
Additional capnographic monitoring of ventilatory activity reduces the incidence of oxygen desaturation and hypoxemia during propofol sedation for colonoscopy.
本随机研究旨在确定基于附加二氧化碳监测的干预措施是否会降低结肠镜检查中异丙酚镇静时动脉血氧饱和度降低的发生率。
接受异丙酚镇静下结肠镜检查的患者(美国麻醉医师协会分类(ASA)1-3 级)被随机分配到标准监测的对照组(标准组)或附加二氧化碳监测的干预组(二氧化碳监测组)。在两个研究组中,当出现呼吸暂停或呼吸改变时,会暂停异丙酚给药,刺激患者、抬起下颌、或采取其他措施。主要研究终点是动脉血氧饱和度降低的发生率(定义为血氧饱和度(SaO2)下降≥5%或<90%);次要终点包括低氧血症(SaO2<90%)、严重低氧血症(SaO2≤85%)、心动过缓、低血压以及镇静质量(患者合作和患者满意度)。
在三个德国内镜中心共纳入了 760 例患者。意向治疗分析显示,二氧化碳监测组的氧饱和度降低发生率明显低于标准组(38.9%比 53.2%;P<0.001)。SaO2<90%和≤85%的患者数量也有显著差异(12.5%比 19.8%;P=0.008 和 3.7%比 7.8%;P=0.018)。心动过缓和低血压的发生率没有差异。两组镇静质量相似。在符合方案人群中,统计分析结果保持不变。
附加的通气活动二氧化碳监测可降低结肠镜检查中异丙酚镇静时氧饱和度降低和低氧血症的发生率。